Status:
UNKNOWN
Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Conditions:
Neuromuscular Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
Non-Invasive Ventilation (NIV) is an established treatment to manage respiratory muscles dysfunction in neuromuscular disease, preventing the progression of respiratory failure to intubation and/or a ...
Eligibility Criteria
Inclusion
- Diagnosis of Neuromuscular Disease (Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Pompe Disease)
- Non Invasive Ventilation \> 16 hours/day
- Informed consent signed
Exclusion
- \- Diagnosis of kyphoscoliosis
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05346263
Start Date
March 1 2022
End Date
March 1 2025
Last Update
December 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
Milan, Italy, 20146